25 series
Export
<<< of 2>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterNarendra Wajapeyee
GSE178211
ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models
18 Narendra Wajapeyee Apr 29, 2024
GSE167071
Analysis of open chromatin structures in HCC827 CBX5 knockdown cells by ATAC seq analysis .
9 Narendra Wajapeyee Feb 18, 2024
GSE150225
The role of MSK1 in pancreatic adenocarcinoma (PDAC) progression
18 Narendra Wajapeyee Nov 02, 2023
GSE165449
Study the differential gene expression in SK-MEL-147 cells treated with different epigenetic modulator
21 Narendra Wajapeyee Nov 01, 2023
GSE146944
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein
9 Narendra Wajapeyee Oct 30, 2023
GSE150222
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein
9 Narendra Wajapeyee Oct 30, 2023
GSE150223
HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway via stimulating MSK1 kinase and suppressing PPP2R2B protein
9 Narendra Wajapeyee Oct 30, 2023
GSE190479
LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition
18 Narendra Wajapeyee Mar 16, 2023
GSE114563
CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer
9 Narendra Wajapeyee Jan 05, 2023
GSE164974
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
12 Narendra Wajapeyee Aug 02, 2022
GSE164976
Transcriptional, chromatin, and metabolic landscapes of LDHA inhibitor–resistant pancreatic ductal adenocarcinoma
12 Narendra Wajapeyee Aug 02, 2022
GSE101399
Study the differential gene expression of different lung cancer EGFR mutants in NIH3T3 cells
15 Narendra Wajapeyee Apr 04, 2022
GSE160176
Study the differential gene expression of C57/BL6 Mouse tumors treated with EZH2 inhibitor GSK343 II
20 Narendra Wajapeyee Oct 25, 2021
GSE166553
Study the differential gene expression of HEPA1-6 tumors in C57/BL6 Mouse tumors treated with vehicle or EZH2 inhibitor GSK343
10 Narendra Wajapeyee Jul 10, 2021
GSE83907
The role of MELK in melanoma progression
12 Narendra Wajapeyee Dec 30, 2020
GSE107184
The role of KLF7 in pancreatic adenocarcinoma (PDAC) progression
9 Narendra Wajapeyee Apr 16, 2020
GSE90483
Loss of thymidine kinase 1 inhibits lung cancer growth and metastatic attributes by reducing GDF15 expression
4 Narendra Wajapeyee Sep 23, 2019
GSE106539
Transcriptome-wide gene expression analysis of the cancer cell lines after treatiment with telomerase inhibitor Imetelstat (GRN163L)
6 Narendra Wajapeyee Jul 19, 2018
GSE76440
Metabolic drivers of ovarian cancer tumor growth
6 Narendra Wajapeyee Aug 13, 2017
GSE62827
Transcriptional targets of oncogenic RAS proteins that mediate their ability to induce cellular transformation
12 Narendra Wajapeyee Sep 08, 2016